Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
We have now added a new section called the "Assay History List" to the "At A Gla...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...